DSNKY (Daiichinkyo Co) Beneish M-Score: -2.06 (As of Jun. 25, 2026)


DSNKY Daiichi Sankyo Co Ltd DSNKY
73 GF Score
Price $15.77
GF Value $39.38
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Daiichinkyo Co Beneish M-Score?

Daiichinkyo Co DSNKY +0.51% 73 Beneish M-Score is -2.06 as of Jun. 25, 2026. GuruFocus rates DSNKY with a GF Score™ of 73/100 and a GF Value™ of $39.38 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 911 Drug Manufacturers companies, Daiichinkyo Co ranks worse than 76.29% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.06 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Daiichinkyo Co's Beneish M-Score or its related term are showing as below:

DSNKY' s Beneish M-Score Range Over the Past 10 Years
Min: -2.92   Med: -2.56   Max: -1.67
Current: -2.06

During the past 13 years, the highest Beneish M-Score of Daiichinkyo Co was -1.67. The lowest was -2.92. And the median was -2.56.


Daiichinkyo Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Daiichinkyo Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiichinkyo Co Beneish M-Score Chart

Daiichinkyo Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.50 -2.28 -2.76 -1.79 -2.06

Daiichinkyo Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.79 0.00 -2.11 -2.19 -2.06

DSNKY vs LLY, JNJ, ABBV: Beneish M-Score Comparison

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Beneish M-Score falls into.


DSNKY
73GF Score
Daiichi Sankyo Co Ltd DSNKY
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiichinkyo Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Daiichinkyo Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0079+0.528 * 1.1337+0.404 * 1.0424+0.892 * 1.1156+0.115 * 1.0034
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9511+4.679 * 0.049195-0.327 * 1.1961
=-2.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $4,671 Mil.
Revenue was 3715.503 + 3579.553 + 3386.624 + 3284.783 = $13,966 Mil.
Gross Profit was 1809.567 + 2820.941 + 2331.728 + 2645.631 = $9,608 Mil.
Total Current Assets was $13,502 Mil.
Total Assets was $25,242 Mil.
Property, Plant and Equipment(Net PPE) was $3,759 Mil.
Depreciation, Depletion and Amortization(DDA) was $510 Mil.
Selling, General, & Admin. Expense(SGA) was $5,144 Mil.
Total Current Liabilities was $5,577 Mil.
Long-Term Debt & Capital Lease Obligation was $1,891 Mil.
Net Income was 267.376 + 555.636 + 306.46 + 591.763 = $1,721 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0 Mil.
Cash Flow from Operations was 163.282 + 513.459 + 55.836 + -253.088 = $479 Mil.
Total Receivables was $4,153 Mil.
Revenue was 3479.789 + 3152.113 + 3123.746 + 2763.05 = $12,519 Mil.
Gross Profit was 2846.893 + 2317.45 + 2438.022 + 2160.934 = $9,763 Mil.
Total Current Assets was $12,810 Mil.
Total Assets was $23,186 Mil.
Property, Plant and Equipment(Net PPE) was $3,344 Mil.
Depreciation, Depletion and Amortization(DDA) was $456 Mil.
Selling, General, & Admin. Expense(SGA) was $4,848 Mil.
Total Current Liabilities was $5,059 Mil.
Long-Term Debt & Capital Lease Obligation was $677 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4670.61 / 13966.463) / (4153.435 / 12518.698)
=0.334416 / 0.331779
=1.0079

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(9763.299 / 12518.698) / (9607.867 / 13966.463)
=0.779897 / 0.687924
=1.1337

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (13501.844 + 3759.471) / 25241.504) / (1 - (12810.035 + 3344.459) / 23186.466)
=0.316153 / 0.303279
=1.0424

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=13966.463 / 12518.698
=1.1156

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(455.512 / (455.512 + 3344.459)) / (510.076 / (510.076 + 3759.471))
=0.119872 / 0.119468
=1.0034

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5144.193 / 13966.463) / (4847.938 / 12518.698)
=0.368325 / 0.387256
=0.9511

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1891.051 + 5577.312) / 25241.504) / ((677.141 + 5058.662) / 23186.466)
=0.295876 / 0.247377
=1.1961

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1721.235 - 0 - 479.489) / 25241.504
=0.049195

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Daiichinkyo Co has a M-score of -2.11 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.06 mean?
Daiichinkyo Co (DSNKY) has a Beneish M-Score of -2.06 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Daiichinkyo Co and its competitors. According to the industry distribution chart, Daiichinkyo Co ranks #695 out of 911 companies in the Drug Manufacturers industry, placing it in the top 76.3%.
Is Daiichinkyo Co's Beneish M-Score too high?
Daiichinkyo Co's current Beneish M-Score is -2.06. Based on the distribution chart, Daiichinkyo Co ranks #695 out of 911 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Daiichinkyo Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's Beneish M-Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Daiichinkyo Co ranks #695 out of 911 companies for Beneish M-Score. This places Daiichinkyo Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Daiichinkyo Co and its competitors. Daiichinkyo Co's current Beneish M-Score is -2.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Based on GuruFocus' analysis, Daiichinkyo Co (DSNKY) is currently considered Significantly Undervalued. The stock's GF Value™ is $39.38, compared to a current price of $15.77 — trading 60% below its estimated fair value. The current Beneish M-Score is -2.06. Daiichinkyo Co's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Daiichinkyo Co (DSNKY), the current Beneish M-Score is -2.06 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daiichinkyo Co (DSNKY) Overvalued in 2026?

Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued. The current stock price of $15.77 is trading 60% below its estimated GF Value™ of $39.38. GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.

Key valuation signals for DSNKY:

  • Beneish M-Score: -2.06
  • GF Value™: $39.38 vs. price of $15.77 (60% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the DSNKY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Daiichinkyo Co Business Description

Address 3-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
73GF Score

Get the complete analysis for DSNKY

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.77
Price
$39.38
GF Value